The Ministry of Food and Drug Safety announced on the 13th that it has expanded the number of drug ingredients providing patient adverse reaction history information through the Drug Utilization Review (DUR) service from the existing 38 to 66, in order to completely prevent patients who have received drug damage relief from being prescribed similar drugs again.


The Drug Utilization Review service is a service that provides real-time drug safety information to doctors and pharmacists, such as drugs that cause adverse reactions or overlap when taken together. This measure is to prevent severe adverse reactions that may occur if patients who have experienced drug side effects are exposed again to the same or similar classes of drugs.


The Ministry of Food and Drug Safety has been gradually expanding the types of drug ingredients providing information, starting with allopurinol (a gout treatment drug that causes severe cutaneous adverse reactions), which is the ingredient with the most damage relief cases. This time, 28 antibiotic ingredients including clarithromycin have been added.


An official from the Ministry of Food and Drug Safety stated, "Since the implementation of the Drug Utilization Review service, there have been no cases where drugs that previously caused adverse reactions were prescribed again to patients who had been provided with drug adverse reaction information through damage relief."



[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing